𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study

✍ Scribed by Birgit Högl; Diego García-Borreguero; Ralf Kohnen; Luigi Ferini-Strambi; Georgios Hadjigeorgiou; Magdolna Hornyak; Al de Weerd; Svenja Happe; Karin Stiasny-Kolster; Viola Gschliesser; Renata Egatz; Birgit Frauscher; Heike Benes; Claudia Trenkwalder; Wayne A. Hening; Richard P. Allen

Publisher
Springer
Year
2009
Tongue
English
Weight
262 KB
Volume
257
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Systematic evaluation of augmentation du
Systematic evaluation of augmentation during treatment with ropinirole in restless legs syndrome (Willis-Ekbom Disease): Results from a prospective, multicenter study over 66 weeks
✍ Diego García-Borreguero; Birgit Högl; Luigi Ferini-Strambi; John Winkelman; Chri 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 915 KB

## Abstract The purpose of this study was to evaluate the incidence of augmentation over 66 weeks of treatment with ropinirole in patients with primary restless legs syndrome (RLS). Augmentation is the main complication of long‐term dopaminergic treatment of RLS. Despite widespread use of ropinirol

Cabergoline compared to levodopa in the
Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: Results from a multi-center, randomized, active controlled trial
✍ Claudia Trenkwalder; Heike Benes; Ludger Grote; Svenja Happe; Birgit Högl; Johan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 1 views

## Abstract We report the first large‐scale double‐blind, randomly assigned study to compare two active dopaminergic therapies for Restless Legs Syndrome (RLS), the dopamine agonist cabergoline (CAB) and levodopa/benserazide (levodopa). Patients with idiopathic RLS were treated with fixed daily dos